Determinants of Health-Related Quality of Life in Outpatients with Myocardial Infarction

DOI: https://doi.org/10.2147/jmdh.s463789

2024-05-07

Journal of Multidisciplinary Healthcare

Abstract:Anan S Jarab, 1– 3 Razan Z Mansour, 3 Suhaib Muflih, 3 Walid Al-Qerem, 4 Shrouq R Abu Heshmeh, 3 Karem H Alzoubi, 5, 6 Yazid N Al Hamarneh, 7 Salah Aburuz, 8 Enaam M Al Momany 9 1 College of Pharmacy, Al Ain University, Abu Dhabi, United Arab Emirates; 2 AAU Health and Biomedical Research Center, Al Ain University, Abu Dhabi, United Arab Emirates; 3 Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, 22110, Jordan; 4 Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman, 11733, Jordan; 5 Department of Pharmacy Practice and Pharmacotherapeutics, University of Sharjah, Sharjah, United Arab Emirates; 6 Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan; 7 Department of Pharmacology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada; 8 Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates; 9 Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa, Jordan Correspondence: Karem H Alzoubi, Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, P.O. Box 3030, Irbid, 22110, Jordan, Email ; Background: The health-related quality of life (HRQOL) of patients with myocardial infarction (MI) is suboptimal because of the disease's life-threatening nature, the requirement for long-term lifestyle modifications, and the treatment regimens following MI. This study aimed to evaluate HRQOL and its associated factors in MI patients. Material and Methods: This study was conducted on patients with MI who attended the outpatient cardiology clinic at a major teaching hospital in Jordan. The EQ-5D-3L questionnaire was used to assess HRQOL of the study participants. Quantile regression analysis was conducted to identify the variables associated with HRQOL. Results: The study included 333 patients with a history of MI, with a median age of 58 (57– 60). The median of the total EQ-5D score was 0.65 (0.216– 0.805). Regression results revealed that male patients (Coefficient= 0.110, 95%Cl (0.022– 0.197), P=0.014) and not being diagnosed with diabetes (Coefficient= 0.154, 95%Cl (0.042– 0.266), P=0.007) were associated with increased HRQOL. On the other hand, low income (Coefficient= − 0.115, 95%Cl (− 0.203 - − 0.026), P=0.011), not receiving DPP-4 (Dipeptidyl Peptidase − 4) inhibitors (Coefficient= − 0.321 95%Cl (− 0.462 - − 0.180), P< 0.001), and having low (Coefficient= − 0.271, 95%Cl (− 0.395 - − 0.147), P< 0.001) or moderate (Coefficient= − 0.123, 95%Cl (− 0.202 - − 0.044), P=0.002) medication adherence was associated with decreased HRQOL. Conclusion: The current study demonstrated diminished HRQOL among patients with MI, highlighting the necessity of tailoring interventions to tackle medication adherence barriers in this population. Personalized interventions such as educational programs, counseling, and reminders that consider each patient's needs and circumstances can greatly enhance medication adherence and, thus, the HRQOL of MI patients. Individuals with lower income levels, female patients, and those with diabetes should be the specific targets of these interventions. Keywords: health-related quality of life, myocardial infarction, EQ-5D, factor, Jordan Myocardial infarction (MI), commonly known as a heart attack, occurs when the blood supply to a portion of the heart muscle is inadequate. 1 In the US, about 1.0 million MIs occur annually and result in death for 300,000 to 400,000 people. 2 The World Health Organization (WHO) placed Jordan at number 65 in the world, with 5248 coronary heart disease fatalities recorded in 2017. 3 In Jordan, the prevalence of MI stands at 5.9%, 4 contributing to 54.7% of all annual deaths. 5 The Economic burden of MI originates from decreased productivity at work, fatalities, first-time hospitalizations, or readmissions. 6 Hospitalization rates were estimated to be 222 per 100,000 patients, 7 and in 2016 currency, the estimated total annual cost of MI was $84.9 billion. 8 The most important risk factors for the development of MI are physical inactivity, smoking, dyslipidemia, diabetes mellitus, hypertension, and obesity. 9 The treatment of MI involves a combination of lifestyle changes, medications, and medical procedures that seek to relieve symptoms, minimize complications, and improve long- -Abstract Truncated-

health care sciences & services